Literature DB >> 7699216

Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

L Chiovato1, P Vitti, G Bendinelli, F Santini, E Fiore, A Capaccioli, M Tonacchera, C Mammoli, M Ludgate, A Pinchera.   

Abstract

Chinese hamster ovary (CHO) cells transfected with the cloned human TSH receptor (CHO-R) were used to develop an assay to detect thyroid autoantibodies blocking the TSH-dependent cAMP production (TSHBAb). The study group included 38 patients with goitrous Hashimoto's thyroiditis (HT) and 47 subjects with atrophic thyroiditis (AT). In the HT group, 8 patients had subclinical hypothyroidism (HT-SH) and 30 had overt hypothyroidism (HT-H). Thirty normal subjects served as controls. Immunoglobulin G (IgG) was prepared from serum by double chromatography on DEAE-Sephadex. CHO-R cells were seeded in 96-well plates and were cultured for 48 h before the assay in RPMI-1640 medium plus 1 mmol/L glutamine, 10% fetal calf serum, and 0.4 g/L geneticin. In the assay for TSHBAb, CHO-R cells were incubated with IgG alone (0.5-2 mg/ml), TSH alone (0.2-625 mU/L), or IgG plus TSH; all samples were diluted in hypotonic medium containing 0.5 mmol/L isobutylmethylxanthine (IBMX). After 2 h of incubation at 37 degrees C in 5% CO2-95% air atmosphere, TSH-stimulation was quantified by measuring extracellular cAMP by a RIA. IgGs from normal subjects did not significantly modify the stimulation of adenylate cyclase produced by TSH, the results obtained ranging between -30% and +18% (mean +/- SD = -3 +/- 14%). All IgGs producing an inhibition greater than 2SD from the mean of controls (> 25%) were considered positive for blocking antibodies. TSHABAb were detected in 1/8 (12.5%) patients with HT-SH, in 7/30 (23.3%) with HT-H and 16/47 (34.0%) patients with AT.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699216     DOI: 10.1007/BF03347782

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism.

Authors:  A Miyauchi; N Amino; H Tamaki; K Kuma
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

2.  Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis.

Authors:  L Chiovato; P Vitti; F Santini; G Lopez; C Mammoli; P Bassi; L Giusti; M Tonacchera; G Fenzi; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

3.  Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.

Authors:  B Y Cho; Y K Shong; H K Lee; C S Koh; H K Min
Journal:  Acta Endocrinol (Copenh)       Date:  1989-01

4.  Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism.

Authors:  N R Steel; D R Weightman; J J Taylor; P Kendall-Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

5.  A new solid-phase immunoradiometric assay for anti-thyroglobulin autoantibody.

Authors:  S Mariotti; S Pisani; A Russova; A Pinchera
Journal:  J Endocrinol Invest       Date:  1982 Jul-Aug       Impact factor: 4.256

6.  Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies.

Authors:  M Ludgate; J Perret; M Parmentier; C Gerard; F Libert; J E Dumont; G Vassart
Journal:  Mol Cell Endocrinol       Date:  1990-10-01       Impact factor: 4.102

7.  Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.

Authors:  P Vitti; C M Rotella; W A Valente; J Cohen; S M Aloj; P Laccetti; F S Ambesi-Impiombato; E F Grollman; A Pinchera; R Toccafondi; L D Kohn
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

8.  Thyroid growth-blocking antibodies in primary myxoedema.

Authors:  H A Drexhage; G F Bottazzo; L Bitensky; J Chayen; D Doniach
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

9.  Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein.

Authors:  S Costagliola; S Swillens; P Niccoli; J E Dumont; G Vassart; M Ludgate
Journal:  J Clin Endocrinol Metab       Date:  1992-12       Impact factor: 5.958

10.  Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins.

Authors:  K Sato; K Okamura; M Yoshinari; H Ikenoue; T Kuroda; M Torisu; M Fujishima
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

View more
  6 in total

1.  Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT).

Authors:  R Elisei; A Pinchera; L Chiovato; C Mammoli; P Agretti; C Romei; F Santini; G Bendinelli; E Fiore; A Capaccioli; P Vitti
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

2.  In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity.

Authors:  F Santini; P Vitti; G Ceccarini; C Mammoli; V Rosellini; C Pelosini; A Marsili; M Tonacchera; P Agretti; T Santoni; L Chiovato; A Pinchera
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

3.  Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.

Authors:  W B Minich; C Lenzner; N G Morgenthaler
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

4.  Comparison of a Novel Homogeneous Cyclic Amp Assay and a Luciferase Assay for Measuring Stimulating Thyrotropin-Receptor Autoantibodies.

Authors:  Tanja Diana; Paul D Olivo; Yie-Hwa Chang; Christian Wüster; Michael Kanitz; George J Kahaly
Journal:  Eur Thyroid J       Date:  2019-11-27

Review 5.  Non-Conventional Clinical Uses of TSH Receptor Antibodies: The Case of Chronic Autoimmune Thyroiditis.

Authors:  Giorgio Napolitano; Ines Bucci; Giulia Di Dalmazi; Cesidio Giuliani
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-05       Impact factor: 5.555

Review 6.  Thyrotropin Receptor Blocking Antibodies.

Authors:  Tanja Diana; Paul D Olivo; George J Kahaly
Journal:  Horm Metab Res       Date:  2018-10-04       Impact factor: 2.936

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.